|
YTHDF1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.130000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.950400E-01 |
| Normal-vs-Stage2 |
6.356400E-02 |
| Normal-vs-Stage3 |
6.820000E-02 |
| Normal-vs-Stage4 |
4.292000E-02 |
| Stage1-vs-Stage2 |
2.641600E-02 |
| Stage1-vs-Stage3 |
2.269500E-02 |
| Stage1-vs-Stage4 |
1.475640E-02 |
| Stage2-vs-Stage3 |
6.141400E-01 |
| Stage2-vs-Stage4 |
8.839200E-01 |
| Stage3-vs-Stage4 |
6.833600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.096400E-02 |
| Normal-vs-AfricanAmerican |
1.067250E-01 |
| Normal-vs-Asian |
1.217500E-02 |
| Caucasian-vs-AfricanAmerican |
1.161550E-03 |
| Caucasian-vs-Asian |
7.484900E-03 |
| AfricanAmerican-vs-Asian |
1.966230E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.078500E-02 |
| Normal-vs-Female |
4.186600E-01 |
| Male-vs-Female |
1.555770E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.187600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.982000E-01 |
| Normal-vs-Age(61-80Yrs) |
3.800600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.531410E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.693400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.672600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.468800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.628000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.538600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.624200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.775400E-01 |
| Normal-vs-Grade 2 |
9.795000E-01 |
| Normal-vs-Grade 3 |
4.654200E-02 |
| Normal-vs-Grade 4 |
3.696100E-02 |
| Grade 1-vs-Grade 2 |
1.557620E-01 |
| Grade 1-vs-Grade 3 |
9.416300E-02 |
| Grade 1-vs-Grade 4 |
1.703790E-02 |
| Grade 2-vs-Grade 3 |
9.603600E-03 |
| Grade 2-vs-Grade 4 |
2.478400E-02 |
| Grade 3-vs-Grade 4 |
6.141600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.938200E-01 |
| Normal-vs-ccB subtype |
1.806560E-01 |
| ccA subtype-vs-ccB subtype |
3.306200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.458600E-01 |
| Normal-vs-N1 |
6.346200E-01 |
| N0-vs-N1 |
9.717000E-01 |
|
|
